Moreover, because the addition of a neutralizing antibody against IGFBP2 only partially suppressed the CAF-like cell-induced migration and invasiveness in three ESCC cell lines, we considered that the paracrine effects of CAF-like cells were not limited to the effects of IGFBP2. Here, IGFBP2 is linked to esophageal squamous cell carcinoma.